Bayer & Bayer — Monsanto

Bayer: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.

Bayer — Monsanto: Bayer — Monsanto, now owned by Bayer, was the direct defendant; the ruling affirms its position that EPA-approved labels preempt state claims.

Bayer: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.

Bayer — Monsanto: Bayer — Monsanto, acquired by Bayer in 2018, is the original maker of Roundup, and its legacy products are at the center of the lawsuits against Bayer.

Bayer — Monsanto: Bayer — Monsanto originally debuted Roundup weedkiller and was acquired by Bayer in 2018, bringing with it the mounting lawsuits related to glyphosate.

Bayer — Monsanto: Bayer — Monsanto, the original developer of glyphosate-based Roundup, was acquired by Bayer and has been at the center of litigation regarding glyphosate's alleged link to cancer.